Participants in the treatment group demonstrated significantly lower IL-6 post-treatment, indicating lower Cardiovascular disease (CVD) risk, compared to those in the information-support condition; however, these significant reductions did not persist at a 1-year follow-up [52]. Here, IL6 is linked to cardiovascular disorder.